Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Colleen McGary, PhD

Theratechnologies

Disclosure(s): Theratechnologies: Employee

Poster(s):

(P-433) Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-453) Cardiovascular Risk Scores and Insulin Resistance are Higher with Excess Visceral Abdominal Fat in People with HIV in the Modern Antiretroviral (ART) Era

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT